B Braun unveils ready-to-use antibiotic system
DUPLEX’s two-compartment, PVC- and DEHP-free design keeps medication and diluent separate until activation
DUPLEX’s two-compartment, PVC- and DEHP-free design keeps medication and diluent separate until activation
Angelini Ventures has already invested €125 million in 22 startups
This is the first time in history that an NDA for a New Chemical Entity (NCE) from an Indian pharmaceutical company has been filed and accepted by the USFDA
Sac-TMT is a novel human TROP2 ADC with proprietary intellectual property, targeting advanced solid tumors
The facility will offer fully equipped wet labs and strategic scientific support for early-stage biotech companies
The formulation is backed by over 80 clinical trials and 200 scientific publications
The high-performance polymer’s transparency and biocompatibility support precise implantation and long-term reliability
The new company aims to transform cutting-edge, highly scalable technologies into innovative drug discovery platforms
Panacea Biotec receives acceptance from CMSS for supply of bOPV
Subscribe To Our Newsletter & Stay Updated